Evidence map›Paper›PMID 29668578›Full record

ArticleMedicine2018

STARD: How many lymph nodals needed to be dissected in corpus carcinoma?

Dehua Ma, Shuping Zhao, Yu Huang, Lei Zhang, Yuan Cao, Yawen Wang

Erratum issuedAbstract read
In one paragraph

Article in Medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Dehua MaThe Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, China, 266000. Qingdao Women and Children Binomial Model from the SEER Database Strict, Qingdao, Shandong Province, China, 266000.
Shuping Zhao
Yu Huang
Lei Zhang
Yuan Cao
Yawen Wang

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During corpus carcinoma surgery, there is uncertainty as to how many lymph nodes should be dissected and examined to determine lymph invasion.In this study, we evaluated a beta-binominal model in data extracted from the Surveillance, Epidemiology, and End Results (SEER) database, which contains 22,372 complete records. We quantified the relationship between examined node number and the probability of missing invaded nodes. Survival curves were used for further validation.We found that for stage T1-T4, 1, 10, 23, and 37 lymph nodes, respectively, needed to be examined to minimize the missing positive nodal probability (1-nodal staging score, NSS) to less than 5%. A hypothetical lymph node examination rate was calculated. Survival rate of T2 and T3 stage samples was significantly associated with NSS, but T1 and T4 sample survival rate was not.The currently dissected nodal should be reduced to 1 to 2 for T1, remains to 10 for T2, and increases to 23 for T3.

Indexed as

Lymph Node ExcisionUterine NeoplasmsFemaleHumansLymphatic MetastasisLymph NodesMiddle AgedModels, StatisticalNeoplasm StagingRisk AssessmentSEER ProgramSurvival Rate

Identifiers

PMID29668578
PMCPMC5916645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.